Porphobilinogen (PBG)

Europe PMC · fetched just now · sorted by publication date

1. 1
   Intravenous hemin for prevention of frequent attacks of acute hepatic porphyria - a double-blind placebo controlled pilot study.

   Moghe A, Kormos-Hallberg C, Villasante-Tezanos A, Anderson KE. · 2026-09-24

   unreviewed
2. 2
   Acute and chronic neurological manifestations of acute porphyria.

   Pischik E. · 2026-09-14

   unreviewed
3. 3
   Milestones in the Elucidation of Heme Biosynthesis.

   Dailey HA. · 2026-09-01

   open access unreviewed
4. 4
   Acute intermittent porphyria presenting with rhabdomyolysis and polyneuropathy with severe quadriparesis and respiratory failure: A case report.

   Bielen L, Vujaklija Brajković A, Zlopaša O, Šućur N, Lovrić M, Šitum A, Stein P. · 2026-09-09

   open access unreviewed
5. 5
   De novo coassembly of functional chlorophyll- and carotenoid-protein complexes in <i>Saccharomyces cerevisiae</i>.

   Li C, Chen GE. · 2026-09-04

   open access unreviewed
6. 6
   Patient-centered and coordinated therapy with RNA interference-based givosiran for acute hepatic porphyria: real-life experience for an ultra-rare disease from Romania.

   Bancos A, Jitaru C, Uhl A, Roibu D, Santa M, Nistor M, Ivancuta A, Moldovan CS, Dima D, Puiu M, Tomuleasa C. · 2026-07-31

   open access unreviewed
7. 7
   Limited benefit of liver transplantation in a boy with biallelic severe deficiency of hydroxymethylbilane synthase and review of prior reported cases.

   Araque M, Ma CD, Jordan A, Faust D, McGuire L, Bonkovsky HL. · 2026-06-27

   open access unreviewed
8. 8
   Givosiran for the Treatment of Hereditary Coproporphyria in Pregnancy: A Case Report.

   Van Schoor T, Nagle SA, Chan RY. · 2026-08-29

   open access unreviewed
9. 9
   Acute Intermittent Porphyria with a Secondary Porphyria Cutanea Tarda-like Biochemical Pattern in a Patient with Co-Morbid Human Immunodeficiency Virus Infection.

   Masemola KM, Masemola KR, Dintshi M, Pillay T. · 2026-07-07

   open access unreviewed
10. 10
    Advanced Management of Acute Intermittent Porphyria: The Role of Givosiran Therapy in Improving Long-Term Outcomes-A Case Study.

    de Araújo Karpejany NRA, do Monte Neto JT, Pereira EM, Carvalho IAF, de Serpa Brandão RMS, da Silva AS, Dos S… · 2026-07-05

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.